{
  "trial_id": "NCT00325442",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, Body weight, Gender, Baseline 6-minute walk distance, PAH etiology (idiopathic/heritable, associated with repaired congenital systemic-to-pulmonary shunts, associated with collagen vascular disease, associated with HIV), Current PAH therapy (endothelin receptor antagonist, phosphodiesterase-5 inhibitor), Duration on current PAH therapy, Previous right heart catheterization results, Previous echocardiography results.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Distance Traversed (meters) During Six Minute Walk Test at Baseline",
          "Baseline 6-minute walk distance"
        ],
        [
          "PAH Etiology",
          "PAH etiology (idiopathic/heritable, associated with repaired congenital systemic-to-pulmonary shunts, associated with collagen vascular disease, associated with HIV)"
        ],
        [
          "Background PAH Therapy",
          "Current PAH therapy (endothelin receptor antagonist, phosphodiesterase-5 inhibitor)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Sex: Female",
        "Male",
        "Baseline WHO Functional Classification"
      ],
      "remaining_candidate_features": [
        "Body weight",
        "Gender",
        "Duration on current PAH therapy",
        "Previous right heart catheterization results",
        "Previous echocardiography results."
      ]
    },
    "processed-gen-response": "Age, Body weight, Gender, Baseline 6-minute walk distance, PAH etiology (idiopathic/heritable, associated with repaired congenital systemic-to-pulmonary shunts, associated with collagen vascular disease, associated with HIV), Current PAH therapy (endothelin receptor antagonist, phosphodiesterase-5 inhibitor), Duration on current PAH therapy, Previous right heart catheterization results, Previous echocardiography results."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Body Weight, Baseline 6-minute walk distance, Type of PAH, Duration of PAH, Current PAH therapy, Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Distance Traversed (meters) During Six Minute Walk Test at Baseline",
          "Baseline 6-minute walk distance"
        ],
        [
          "PAH Etiology",
          "Type of PAH"
        ],
        [
          "Background PAH Therapy",
          "Current PAH therapy"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Baseline WHO Functional Classification"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Body Weight",
        "Duration of PAH",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure",
        "Heart Rate"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Body Weight, Baseline 6-minute walk distance, Type of PAH, Duration of PAH, Current PAH therapy, Systolic Blood Pressure, Diastolic Blood Pressure, Heart Rate"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Body Weight, PAH Etiology, 6-Minute Walk Distance, WHO Functional Class, Systolic Pulmonary Artery Pressure, Mean Pulmonary Artery Pressure, Cardiac Output, Pulmonary Vascular Resistance, NT-proBNP, Borg Dyspnea Index.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Distance Traversed (meters) During Six Minute Walk Test at Baseline",
          "6-Minute Walk Distance"
        ],
        [
          "PAH Etiology",
          "PAH Etiology"
        ],
        [
          "Baseline WHO Functional Classification",
          "WHO Functional Class"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Background PAH Therapy"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Region of Enrollment",
        "Body Weight",
        "Systolic Pulmonary Artery Pressure",
        "Mean Pulmonary Artery Pressure",
        "Cardiac Output",
        "Pulmonary Vascular Resistance",
        "NT-proBNP",
        "Borg Dyspnea Index"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Body Weight, PAH Etiology, 6-Minute Walk Distance, WHO Functional Class, Systolic Pulmonary Artery Pressure, Mean Pulmonary Artery Pressure, Cardiac Output, Pulmonary Vascular Resistance, NT-proBNP, Borg Dyspnea Index."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, body weight, PAH etiology (idiopathic/heritable, associated with appetite suppressant/toxin use, associated with repaired congenital systemic-to-pulmonary shunts, associated with collagen vascular disease, associated with HIV), baseline 6-minute walk distance, duration of PAH diagnosis, duration of current PAH therapy, type of current PAH therapy (endothelin receptor antagonist and/or phosphodiesterase-5 inhibitor), systolic blood pressure, diastolic blood pressure, heart rate, New York Heart Association (NYHA) functional class.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Distance Traversed (meters) During Six Minute Walk Test at Baseline",
          "baseline 6-minute walk distance"
        ],
        [
          "PAH Etiology",
          "PAH etiology (idiopathic/heritable, associated with appetite suppressant/toxin use, associated with repaired congenital systemic-to-pulmonary shunts, associated with collagen vascular disease, associated with HIV)"
        ],
        [
          "Background PAH Therapy",
          "type of current PAH therapy (endothelin receptor antagonist and/or phosphodiesterase-5 inhibitor)"
        ]
      ],
      "remaining_reference_features": [
        "Categorical",
        "Male",
        "Baseline WHO Functional Classification"
      ],
      "remaining_candidate_features": [
        "body weight",
        "duration of PAH diagnosis",
        "duration of current PAH therapy",
        "systolic blood pressure",
        "diastolic blood pressure",
        "heart rate",
        "New York Heart Association (NYHA) functional class."
      ]
    },
    "processed-gen-response": "Age, sex, body weight, PAH etiology (idiopathic/heritable, associated with appetite suppressant/toxin use, associated with repaired congenital systemic-to-pulmonary shunts, associated with collagen vascular disease, associated with HIV), baseline 6-minute walk distance, duration of PAH diagnosis, duration of current PAH therapy, type of current PAH therapy (endothelin receptor antagonist and/or phosphodiesterase-5 inhibitor), systolic blood pressure, diastolic blood pressure, heart rate, New York Heart Association (NYHA) functional class."
  }
}